AG001EYE

147526-32-7 | 6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E)-

Chemical structure of 6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E)-, CAS 147526-32-7
AG001EYE
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 147526-32-7
Catalog Number AG001EYE(AGN-PC-0Q0GQE)
Chemical Name 6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E)-
IUPAC Name calcium;(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate
InChI InChI=1S/2C25H24FNO4.Ca/c2*26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-18(28)13-19(29)14-23(30)31;/h2*1-4,7-12,16,18-19,28-29H,5-6,13-14H2,(H,30,31);/q;;+2/p-2/b2*12-11+;/t2*18-,19-;/m11./s1
InChI Key RHGYHLPFVJEAOC-FFNUKLMVSA-L
MDL Number MFCD01937979
Molecular Formula C50H46CaF2N2O8
Molecular Weight 880.9836
SMILES O=C([O-])C[C@H](O)C[C@H](O)/C=C/C1=C(C2=CC=C(F)C=C2)C3=CC=CC=C3N=C1C4CC4.O=C([O-])C[C@H](O)C[C@H](O)/C=C/C5=C(C6=CC=C(F)C=C6)C7=CC=CC=C7N=C5C8CC8.[Ca+2]
UNII IYD54XEG3W
Synonyms
(E,3R,5S)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid, itavastatin, itavastatin calcium, nisvastatin, NK 104, NK-104, P 872441, P-872441, pitavastatin, pitavastatin calcium, pitavastatin lactone, Pitavastatin calcium, 147526-32-7, Livalo, Pitavastatin hemicalcium, NK-104, UNII-IYD54XEG3W, Flovas, IYD54XEG3W, Nisvastatin, 2C25H23FNO4.Ca, Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate, CHEBI:71258, NK 104 (acid), Itavastatin calcium, Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt, Pitavastatin calcium (JAN), Alipza, Livazo, 147511-69-1, P 872441, P-872441, (+)-monocalciumbis{(3r,5s,6e)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-hepten, 6-Heptenoic acid, 7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl)-3,5-dihydroxy-, calcium salt (2:1), (S-(R*,S*-(E)))-, calcium (E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate, Pitavastatin calcium salt, Redevant, CCRIS 8652, AK-50694, Livalo (TN), AC1NR03G, SCHEMBL22720, CHEMBL1237061, DTXSID4046448, CHEBI:94569, NKS-104, RHGYHLPFVJEAOC-FFNUKLMVSA-L, ACT02718, calcium;(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate, 2299AH, MFCD01937979, AKOS015900407, AM84441, AN-6862, AT-3425, KS-1220, 111GE002, BC654789, BR-50694, LS-74595, SC-18906, AB2000276, ST24030237, D01862, Q-201590, (+)-MONOCALCIUMBIS[(3R,5S,6E)-7-[2-CYCLOPROPYL-4(4-FLUOROPHENYL)-3-QUINOLYL]3,5-DIHYDROXY-6-HEPTENO ATE], (3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid hemicalcium salt, 6-Heptenoic acid, 7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl)-3,5-dihydroxy-,calcium salt (2:1), (3R,5S,6E)-, 6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E)-, Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate) monocalcium salt, calcium (E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-hept-6-enoate, calcium(2+) bis((3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate), Pitavastatin, Itavastatin, Vezepra, Pitavastatin [INN], Pitavastatin calcium?, D0H9WN, NK 104, UNII-M5681Q5F9P, C25H24FNO4, C25H24FNO4.1/2Ca, C25-H24-F-N-O4, ACN-048271, CID5282451, CS-O-30720, C25-H24-F-N-O4.1/2Ca, Pitavastatin calcium, 99% - 10MG 10mg, A10737, ( )-(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid, (+) Monocalcium bis [(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate], (+)- Monocalcium bis [(3R,5S,6E)-7-[2-cyclopropyl-4-(4- fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate], (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid, (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid, 10031-30-8, calcium bis{(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate},

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited